Operon S.A.
PCR-Based Genomic Strip Assays
In the United States, Oasis Diagnostics® Corporation is the authorized representative for Operon S.A. (Zaragoza, Spain) products. Genomic kits from Operon are based on the capture with specific probes of nucleic acids of amplified fragments by the polymerase chain reaction. Kits are typically 16 tests. Operon was established in 1973 as a private R&D laboratory in the field of immunochemistry.
Key Features
PCR-Based Strip Technology
Kits based on capture with specific probes of nucleic acids from PCR-amplified fragments, delivered in a convenient strip format for clear, easy-to-read results.
Celiac & Genetic Testing
Targeted assays for celiac disease susceptibility, Y-chromosome analysis, and HLA-B5701 typing to support pharmacogenomic screening.
Infectious Disease Panels
PapillomaStrip assays covering high-risk and high+low risk HPV, plus OligoGen assays for Chlamydia trachomatis, HSV, and Neisseria gonorrhoeae.
Established R&D Heritage
Founded in 1973 as a private R&D laboratory in immunochemistry, Operon S.A. brings decades of diagnostic innovation to genomic testing.
For Research Use Only (RUO)
Operon S.A. is intended for research use only in the United States and is not FDA-cleared for diagnostic use.